Cardiovascular dysfunction in parkinsonian disorders
Mathias, C.J.
Functional Neurology 16(3): 257-265
2001
ISSN/ISBN: 0393-5264 PMID: 11769871 Document Number: 529810
Document emailed within 1 workday
Related Documents
Etcharry-Bouyx, F.; Gambarelli, D.; Kassis, N.; Gosset, A.; Bonnefoi-Kyriacou, B.; Viallet, F. 1995: Cognition disorders and parkinsonian syndrome: diffuse Lewy body disease? Revue Neurologique (Paris) 151(6-7): 410-412Shukla, G.; Behari, M. 2004: A clinical study of non-parkinsonian and non-cerebellar tremor at a specialty movement disorders clinic Neurology India 52(2): 200-202
Bertrand, M.E. 1997: Endothelial dysfunction in cardiovascular pathology Archives des Maladies du Coeur et des Vaisseaux 90(Special Issue 6): 7
Saini, H.K.; Arneja, A.S.; Dhalla, N.S. 2004: Role of cholesterol in cardiovascular dysfunction Canadian Journal of Cardiology 20(3): 333-346
Smith, E.R. 1999: Erectile dysfunction in the cardiovascular patient Canadian Journal of Cardiology 15(2): 233-235; 237
Langton, P.E. 2000: Erectile dysfunction, sildenafil and cardiovascular risk Medical Journal of Australia 173(8): 446
Cirillo, M.; Del Giudice, L.; Bilancio, G.; Chiricone, D.; Franzese, M.D.; De Santo, N.G. 2009: Renal dysfunction as a marker of cardiovascular risk Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(Suppl 46): 79-82
Huval, W.V.; Dunham, B.M.; Lelcuk, S.; Valeri, C.R.; Shepro, D.; Hechtman, H.B. 1983: Thromboxane mediation of cardiovascular dysfunction following aspiration Surgery 94(2): 259-266
Abu-Sittah, G.S.; Sarhane, K.A.; Dibo, S.A.; Ibrahim, A. 2012: Cardiovascular dysfunction in burns: review of the literature Annals of Burns and Fire Disasters 25(1): 26-37
Chew, K.K.; Stuckey, B.G.; Thompson, P.L. 2000: Erectile dysfunction, sildenafil and cardiovascular risk Medical Journal of Australia 172(6): 279-283
Hirata, N.; Matsuda, H. 1997: Cardiovascular surgery in the patients with liver dysfunction Nihon Geka Gakkai Zasshi 98(8): 671-675
Wiersinga, W.M. 2012: Cardiovascular risks in patients with subclinical thyroid dysfunction Nederlands Tijdschrift Voor Geneeskunde 156(49): A5477
Irekpita, E.; Salami, T.A. 2009: Erectile dysfunction and its relationship with cardiovascular risk factors and disease Saudi Medical Journal 30(2): 184-190
Liu, Y. 2013: Cardiovascular-protective effect of tadalafil in the treatment of erectile dysfunction Zhonghua Nan Ke Xue 19(12): 1147-1151
Feener, E.P.; King, G.L. 2001: Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease Heart Failure Monitor 1(3): 74-82
Mittal, S.R. 2012: LV remodeling and/or diastolic dysfunction in normal persons with BP of 120/80 mm hg or less and no other cardiovascular risk factors Journal of the Association of Physicians of India 60: 18-20
Jackson, G.; Betteridge, J.; Dean, J.; Hall, R.; Holdright, D.; Holmes, S.; Kirby, M.; Riley, A.; Sever, P. 1999: A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement International Journal of Clinical Practice 53(6): 445-451
Tinti, F.; Mitterhofer, A.P.; Muiesan, P. 2012: Liver transplantation: role of immunosuppression, renal dysfunction and cardiovascular risk factors Minerva Chirurgica 67(1): 1-13
Saraswathi, P.V.; Neelambikai, N.; Mahesh, A.; Govindarajan, K. 2013: Cardiovascular parasympathetic nervous system dysfunction in female rheumatoid arthritis patients Indian Journal of Physiology and Pharmacology 57(1): 23-30
Buranakitjaroen, P.; Mangklabruks, A.; Leungwattanakij, S.; Ngaothamatasn, W.; Malhotra, C.; Chee, C.; Mohamed, S.Raja.; Dato'Johan, R.Malek. 2007: Efficacy and safety of sildenafil in Asian males with erectile dysfunction and cardiovascular risk Journal of the Medical Association of Thailand 90(6): 1100-1108